$TJ DaRenTang USD (T14.SG)$ Glove and healthcare stocks have...

Glove and healthcare stocks have been rising due to concerns that the Covid situation in China may worsen. Tianjin Pharmaceutical Da Ren Tang Group may be another potential and perhaps more direct beneficiary. It is an illiquid stock. But it's a large company and may catch the attention of institutions. Volume will improve if it happens.

T14's A shares (600329 CH) is covered by three houses with an average tp of CNY40.82 which translates to around USD5.75. It is noteworthy that all three houses' reports are very recent with the latest dated on 13 Dec 2022. If these houses are correct and if A share trades back to its average 3.01x to T14 share price, this may indicate a USD1.91 price for T14, representing a whopping potential capital upside of around 74%.

But from my experience it doesn't rise to the tp. So it may rise about 30% in the short to medium term.